Grant: Collaborative Research and Development Grants
Queen's University
$59,064.00
Synthetic methodologies for the construction of novel nucleoside derivatives with potential antiviral and anticancer activity
FY 2017-18
Summary
Nucleosides and nucleotides are essential biomolecules for the functioning of cellular systems in all living organisms. Both nucleosides and nucleotides have been developed as drug molecules, but nucleosides possess enhanced physicochemical properties that allow them to penetrate cell membranes. Moreover, nucleosides are readily converted into active nucleotides via cellular phosphorylation processes, such as cell signaling, DNA and RNA synthesis, enzyme regulation and metabolism. Therefore, new and improved synthetic routes for nucleosides are of considerable interest in drug discovery programs of and will benefit many Canadian and international pharmaceutical companies. This research proposal aims to develop efficient synthetic methods for the preparation of nucleoside analogues bearing original features such as: a) introduction of functional groups at the 1' position and b) conformational restriction of the sugar backbone. The introduction of these structural elements will provide opportunities for novel interactions with biological targets of interest in the fields of anticancer and antiviral drug discovery. By targeting such nucleosides, this collaboration will lead to low-cost and locally produced medicines for Canadians, all while aiding to develop young scientific minds that would otherwise not have the opportunity to participate in high-impact industrial collaborations at the undergraduate level.
Program
Collaborative Research and Development Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
507457-2016
Name nom
Snieckus, Victor
Department département
Chemistry
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2016
Award amount
59064
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
1
Nb partie
1
Application title
Synthetic methodologies for the construction of novel nucleoside derivatives with potential antiviral and anticancer activity
Keyword
NSERC
Application summary
Nucleosides and nucleotides are essential biomolecules for the functioning of cellular systems in all living organisms. Both nucleosides and nucleotides have been developed as drug molecules, but nucleosides possess enhanced physicochemical properties that allow them to penetrate cell membranes. Moreover, nucleosides are readily converted into active nucleotides via cellular phosphorylation processes, such as cell signaling, DNA and RNA synthesis, enzyme regulation and metabolism. Therefore, new and improved synthetic routes for nucleosides are of considerable interest in drug discovery programs of and will benefit many Canadian and international pharmaceutical companies. This research proposal aims to develop efficient synthetic methods for the preparation of nucleoside analogues bearing original features such as: a) introduction of functional groups at the 1' position and b) conformational restriction of the sugar backbone. The introduction of these structural elements will provide opportunities for novel interactions with biological targets of interest in the fields of anticancer and antiviral drug discovery. By targeting such nucleosides, this collaboration will lead to low-cost and locally produced medicines for Canadians, all while aiding to develop young scientific minds that would otherwise not have the opportunity to participate in high-impact industrial collaborations at the undergraduate level.